retatrutide phase 2 diabetes trial 2: Type Weight Loss and Key Findings – Bolt Pharmacy Media Centre | EASD
Description
For studies tracking gastrointestinal tolerability during the retatrutide escalation schedule, meal size and composition are important confounding variables
Kumar R, Rizvi MR, Saraswat S
Wang G, Gao S, Su N, Xu J, Fu D
Y.SattarN.Pop-BusuiR.DeanfieldJ.EmersonS
The popularity of GLP-1 weight-loss medications continues to soarand their uptake is helping to push down obesity rates on a national scalebut a safe, evidence-based way off the drugs isnt yet in clear view
